Claudio Flores

746 total citations
41 papers, 493 citations indexed

About

Claudio Flores is a scholar working on Oncology, Epidemiology and Cancer Research. According to data from OpenAlex, Claudio Flores has authored 41 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Epidemiology and 9 papers in Cancer Research. Recurrent topics in Claudio Flores's work include Breast Cancer Treatment Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Claudio Flores is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Claudio Flores collaborates with scholars based in Peru, United States and Brazil. Claudio Flores's co-authors include Joseph A. Pinto, Alfredo Aguilar, Jhajaira M. Araujo, Zaida Morante, Denisse Bretel, Carlos Vallejos, Luís Más, Rossana Ruiz, J. Smith Torres‐Roman and Henry Gómez and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Claudio Flores

36 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Flores Peru 11 278 136 101 85 85 41 493
Vivek Khemka United States 8 371 1.3× 104 0.8× 120 1.2× 71 0.8× 142 1.7× 23 519
Kelsey L. Corrigan United States 12 296 1.1× 97 0.7× 154 1.5× 93 1.1× 46 0.5× 52 585
Alfonso Yubero Spain 13 486 1.7× 125 0.9× 40 0.4× 57 0.7× 44 0.5× 45 584
Miriam Rottmann Germany 11 197 0.7× 79 0.6× 43 0.4× 116 1.4× 94 1.1× 23 526
Giuseppa Scandurra Italy 11 243 0.9× 91 0.7× 34 0.3× 113 1.3× 72 0.8× 47 498
Ainhoa Madariaga Spain 11 415 1.5× 80 0.6× 88 0.9× 227 2.7× 90 1.1× 51 703
Carolyn Nessim Canada 15 306 1.1× 141 1.0× 42 0.4× 169 2.0× 118 1.4× 51 571
Francesca Fioretti Italy 13 252 0.9× 89 0.7× 108 1.1× 100 1.2× 37 0.4× 18 547
Whitney A. Spannuth Graybill United States 13 221 0.8× 54 0.4× 60 0.6× 154 1.8× 60 0.7× 40 549
Monica Verrico Italy 11 251 0.9× 49 0.4× 40 0.4× 128 1.5× 91 1.1× 31 484

Countries citing papers authored by Claudio Flores

Since Specialization
Citations

This map shows the geographic impact of Claudio Flores's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Flores with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Flores more than expected).

Fields of papers citing papers by Claudio Flores

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Flores. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Flores. The network helps show where Claudio Flores may publish in the future.

Co-authorship network of co-authors of Claudio Flores

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Flores. A scholar is included among the top collaborators of Claudio Flores based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Flores. Claudio Flores is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruiz, Rossana, Claudio Flores, Natalia Valdiviezo, et al.. (2024). Clinical and outcome patterns in epithelial ovarian cancer (EOC) within a Latin American cohort.. Journal of Clinical Oncology. 42(16_suppl). e23308–e23308. 1 indexed citations
2.
Flores, Claudio, et al.. (2024). S4481 Challenges in Managing Hepatitis B Reactivation in an HIV-Positive Patient on Dialysis for End-Stage Renal Disease. The American Journal of Gastroenterology. 119(10S). S2861–S2861.
3.
Saravia, Luis, et al.. (2024). Self-medication Practices During the Covid-19 Pandemic in a Latin American Country: A Cross-sectional Survey Study. INQUIRY The Journal of Health Care Organization Provision and Financing. 61. 2876895035–2876895035. 2 indexed citations
4.
Flores, Claudio, et al.. (2023). COVID-19 IMPACT ON HUMAN PAPILLOMAVIRUS IMMUNIZATION PROGRAM IN PERU: MODELLING TIME AND CATCH-UP RATES TO CLOSE THE IMMUNIZATION GAP. International Journal of Infectious Diseases. 130. S124–S124.
5.
Flores, Claudio, et al.. (2023). The impact of treatment adherence on overall survival in non-metastatic colorectal cancer in Latin American patients.. Journal of Clinical Oncology. 41(16_suppl). e15644–e15644. 1 indexed citations
6.
Pineau, Pascal, Claudio Flores, Luis Cano, et al.. (2021). A preoperative nomogram for predicting long-term survival after resection of large hepatocellular carcinoma (>10 cm). HPB. 24(2). 192–201. 12 indexed citations
7.
Ku, Gabriel De la Cruz, Diego Chambergo‐Michilot, J. Smith Torres‐Roman, et al.. (2020). Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer. PLoS ONE. 15(12). e0243447–e0243447. 12 indexed citations
8.
Morante, Zaida, Rossana Ruiz, Jhajaira M. Araujo, et al.. (2020). Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer. Clinical Breast Cancer. 21(3). 239–246.e4. 17 indexed citations
9.
Pinto, Joseph A., Claudio Flores, Jhajaira M. Araujo, et al.. (2019). Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America. ecancermedicalscience. 13. 896–896. 8 indexed citations
10.
Pinto, Joseph A., Cynthia Villarreal‐Garza, Zaida Morante, et al.. (2019). Barriers in Latin America for the management of locally advanced breast cancer. ecancermedicalscience. 13. 897–897. 31 indexed citations
11.
Montenegro, Paola, et al.. (2019). Risk factors predicting colorectal cancer recurrence in a Latin American population.. Journal of Clinical Oncology. 37(15_suppl). e15180–e15180. 1 indexed citations
12.
Pinto, Joseph A., Carlos Vallejos, Luis E. Raez, et al.. (2018). Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?. ESMO Open. 3(3). e000344–e000344. 123 indexed citations
13.
Castillo, Miluska, et al.. (2018). MGMT promoter methylation in Peruvian patients with glioblastoma. ecancermedicalscience. 12. 812–812. 1 indexed citations
14.
Araujo, Jhajaira M., Alfredo Aguilar, Roberto Salgado, et al.. (2018). Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer. Scientific Reports. 8(1). 4899–4899. 72 indexed citations
15.
Castañeda, Carlos A., et al.. (2014). Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma. Hematology/Oncology and Stem Cell Therapy. 7(4). 149–156. 7 indexed citations
16.
Gómez, Henry, Frank Campana, Silvia P. Neciosup, et al.. (2012). Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma. Hematology/Oncology and Stem Cell Therapy. 5(3). 152–157. 1 indexed citations
17.
Vega, Estela, Eva Ciruelos, Natalia Valdiviezo, et al.. (2011). Lobular carcinoma of the breast: outcome of 205 patients. Breast Cancer Research. 13(S2). 1 indexed citations
18.
Barrionuevo, Carlos, et al.. (2007). Extranodal NK/T-cell Lymphoma, Nasal Type: Study of Clinicopathologic and Prognosis Factors in a Series of 78 Cases From Peru. Applied immunohistochemistry & molecular morphology. 15(1). 38–44. 57 indexed citations
19.
Santolaya, Marı́a Elena, Ricardo Rabagliati, Ernesto Payá, et al.. (2005). Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre. Revista chilena de infectología. 79–113. 10 indexed citations
20.
Pineda, C., et al.. (2005). Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: A phase II trial. Gynecologic Oncology. 100(1). 70–75. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vivek Khemka Breakdown of academic impact, for papers by Kelsey L. Corrigan Breakdown of academic impact, for papers by Alfonso Yubero Breakdown of academic impact, for papers by Miriam Rottmann Breakdown of academic impact, for papers by Giuseppa Scandurra Breakdown of academic impact, for papers by Ainhoa Madariaga Breakdown of academic impact, for papers by Carolyn Nessim Breakdown of academic impact, for papers by Francesca Fioretti Breakdown of academic impact, for papers by Whitney A. Spannuth Graybill Breakdown of academic impact, for papers by Monica Verrico
Rankless by CCL
2026